20 July 2021
BDA advises Navis on the sale of majority stake in OPV Pharmaceuticals to RV Healthcare
Divested majority stake in OPV Pharmaceuticals to RV Healthcare
2021
Recent transactions
Received investment from TA Associates
2023
Acquired Shenzhen Wikkon
2022
Divested B Medical Systems to Azenta
2022
Agreed to divest East Syracuse, New York facility to LOTTE Corporation
2022
Sold minority stake to Quadria Capital
2022
Acquired by Novo Holdings
2022
Investment from The Riverside Company
2021
Acquired by MicroPort
2021
Acquired by Mindray
2021
Divested majority stake to DCP Capital
2021
Agreed to divest Couvet, Switzerland facility to WuXi AppTec
2021
Raised Series B round from ABC World Asia
2021
Divested Neoss to CareCapital
2020
Divested Escientia Life Sciences to Deccan Fine Chemicals
2020
Divested significant stake in Kehua Bio-Engineering to Gree Real Estate
2020
Divested LAP Laser to IK Investment Partners
2019
Divested majority stake to The Longreach Group
2019
Divested plant health business in Japan to Nisso
2018
Divested The Ritedose Corporation to AGIC and Humanwell
2017
Majority recapitalized by Galen Partners
2017